Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.

Researchers say a generic version could be made for just $25 per person a year.

Capitalism kills.

@luckytran @skye I maintain that mandatory licensing of medicines, with a licensing fee determined by an independent court, is the best way to deal with this. The inventor of the medicine gets paid for their discovery, but they do not get to set the price. And then anyone can license the medicine at that price and produce it and sell it on the market.